Menu
Neurovalens Limited has received support for research and development from Invest Northern Ireland under the European Union’s Investment for Growth and Jobs Programme.
This ’Vestal Medical Device for Weight Loss’ project will be developed and implemented over the next two years, performing research and development activities aimed at tackling obesity.
This project which is part-financed by the European Regional Development Fund under the Investment for Growth and Jobs Programme 2014-2020 aims to increase business efficiency.
Invest Northern Ireland have provided Neurovalens Limited support for research and development under the European Union’s Investment for Growth and Jobs Programme.
This ’Neuromodulation for Anxiety Disorders’ project will be developed and implemented over the next two years, performing research and development activities addressing anxiety.
Part-financed by the European Regional Development Fund under the Investment for Growth and Jobs Programme 2021-2024; this project aims to increase business efficiency.
Keep up to date with our latest products, research and company news.
Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world’s greatest health challenges.
Our medical device technology offers unparalleled transdermal activation of the homeostatic nuclei of the brainstem and hypothalamus, allowing for alterations in autonomic function, circadian regulation and Neuro-metabolic influence.
